Intravenous pamidronate treatment in children with moderate to severe osteogenesis imperfecta: assessment of indices of dual-energy X-ray absorptiometry and bone metabolic markers during the first year of therapy.

Source:http://linkedlifedata.com/resource/pubmed/id/15003801

Download in:

View as

General Info

PMID
15003801